HIV阳性肝移植受者免疫抑制治疗下T细胞 compartment 高效
研究比较HIV阳性与阴性肝移植受者免疫抑制治疗后T细胞表型与多功能性,发现HIV阴性移植受者具有更多耗竭或炎症性T细胞,而HIV阳性患者因既往HIV相关免疫抑制对抗排斥治疗反应不同。
要点
- HIV阴性肝移植受者较HIV阳性者显示更多耗竭或炎症性T细胞。
- HIV阳性患者既往免疫抑制史可能改变对抗排斥治疗的反应。
- 移植后细胞免疫功能性评估对感染防控有潜在意义。
核心结论
- HIV阴性肝移植受者比HIV阳性受者具有更多耗竭或炎症性T细胞,提示既往HIV感染相关免疫抑制可改变对抗排斥治疗的反应。
研究设计与样本
- 研究纳入108名受试者,分为4组各27人:HIV阳性移植受者、HIV阴性移植受者、HIV阳性非移植患者和健康对照,采用流式细胞术分析T细胞活化、分化和细胞因子产生。
主要发现
- HIV阳性患者中位CD4计数为567 cells/mL,所有患者病毒载量均检测不到。
- HIV阳性与HIV阴性肝移植受者的CD4+和CD8+ T细胞亚群分布不同。
- HIV阴性移植受者中表达PD1的效应细胞群丰富,且具有更高水平的能产生干扰素-γ和肿瘤坏死因子-α的CD4+ T细胞。
临床怎么用
- 临床需认识到HIV阴性肝移植受者可能表现出更显著的T细胞耗竭或炎症状态,而HIV阳性受者因既往免疫抑制经历对抗排斥治疗反应不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients undergoing orthotopic liver transplant (OLT), immunosuppressive treatment is mandatory and infections are leading causes of morbidity/mortality. Thus, it is essential to understand the functionality of cell-mediated immunity after OLT. The aim of the study was to identify changes in T-cell phenotype and polyfunctionality in human immunodeficiency virus-positive (HIV+) and -negative (HIV-) patients undergoing immunosuppressive treatment after OLT. METHODS: We studied peripheral blood mononuclear cells from 108 subjects divided into 4 groups of 27: HIV+ transplanted patients, HIV- transplanted patients, HIV+ nontransplanted patients, and healthy subjects. T-cell activation, differentiation, and cytokine production were analyzed by flow cytometry. RESULTS: Median age was 55 years (interquartile range, 52-59 years); the median CD4 count in HIV+ patients was 567 cells/mL, and all had undetectable viral load. CD4+ and CD8+ T-cell subpopulations showed different distributions between HIV+ and HIV- OLT patients. A cluster representing effector cells expressing PD1 was abundant in HIV- transplanted patients and they were characterized by higher levels of CD4+ T cells able to produce interferon-γ and tumor necrosis factor-α. CONCLUSIONS: HIV- transplanted patients have more exhausted or inflammatory T cells compared to HIV+ transplanted patients, suggesting that patients who have already experienced a form of immunosuppression due to HIV infection respond differently to anti-rejection therapy.
引用
- Franceschini E, De Biasi S, Digaetano M, et al. Efficient T-Cell Compartment in HIV-Positive Patients Receiving Orthotopic Liver Transplant and Immunosuppressive Therapy. J Infect Dis. 2021. PMID: 32620016. doi:10.1093/infdis/jiaa395
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。